The SQUEEZE project will help with the optimization of existing treatments for Rheumatoid Arthritis (RA) by exploring the latest developments in the field of biomarkers. We are focusing on the effect and safety of medicines, and analyse the best implementation science to enhance the therapeutic relationship between patients and doctors.

Welcome to the SQUEEZE Project

Rheumatoid arthritis (RA) is a chronic immune-mediated condition with enormous socioeconomic and individual impact. Despite the availability of various treatment options, every patient seems to respond differently. ​Furthermore, the unsuccessful choice of the most suitable medication for a particular patient can lead to a scenario in which the patient consumes a drug that doesn’t align with their body’s response, ultimately aggravating the patient’s condition. We, at SQUEEZE, in synergy with other EU-wide activities, work to validate clinical, laboratory, molecular, digital, and behavioural biomarkers to help tailor the best treatment to the individual patient.Our aim is to improve the efficacy, safety, and satisfaction with existing therapies (by squeezing the most out of them!).



€ 12.5 Mio

5 years


We are a team of leading academic centres with a first-class record in translational and clinical research, patient research partners and small and medium sized enterprises (SME) active in the field of innovative digital healthcare products, science communication, and project management.

SQUEEZE project

We aim to have a real impact on the life of people with rheumatoid arthritis


The SQUEEZE team at the EULAR 2024 Congress in Vienna

June 20th, 2024|

The SQUEEZE project proudly participated in the EULAR 2024 Congress in Vienna. At the SQUEEZE booth, EULAR-trained Patient Research Partners from PARE as well as all our WP leaders engaged in "Meet the Expert" [...]

2nd issue of our SQUEEZE newsletter published

December 14th, 2023|

We published the 2nd issue of our SQUEEZE newsletter on our LinkedIn channel!! 🗞️💊 On a bi-annual basis, we will provide you with insights into our daily collaboration within our 13 partners Horizon Europe [...]